We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.50 | 56.00 | 59.00 | 57.50 | 57.50 | 57.50 | 554 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 29.49M | -302k | -0.0043 | -133.72 | 40.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/3/2021 12:23 | The trades at .678p are buys - I just topped up at .6778p | channel pirate | |
05/3/2021 12:07 | Who knows. The share price action this morning isn't particularly encouraging... | cyberbub | |
05/3/2021 08:40 | cyberbub >> You think the overhang has gone now? | topnotch | |
04/3/2021 14:40 | Massive 60M trade gone through, almost 1% of the company. I suspect it must be a sell worked over a few days. Let's see if we get a reversal now?? | cyberbub | |
03/3/2021 11:51 | Looks like the trend lines are being followed almost perfectly since late Dec and I did expect this to touch 0.7p (mid) so hoping we have a solid bounce from here! | topnotch | |
02/3/2021 12:07 | SP closed bang on the 20 SMA. Let's see if we find support again around these levels, touch wood.... | cyberbub | |
26/2/2021 07:31 | Having Glenn as permanent chairman makes sense to me. I was impressed by him at CSRT. | cerrito | |
25/2/2021 11:56 | Chart suggesting next breather .9p | red army | |
25/2/2021 09:29 | Looking good for a rise up today | monster500 | |
24/2/2021 18:27 | Nice close. Let's see if volume picks up in the coming days. Would be good to see a run towards 1p, I don't think that would be expensive given the prospects and IP here.NAI | cyberbub | |
24/2/2021 14:31 | Nice share price action so far | cyberbub | |
24/2/2021 13:21 | Bit quiet on here? | cyberbub | |
19/2/2021 16:56 | They've trimmed a little after the big rise. No big deal IMO. | cyberbub | |
19/2/2021 16:46 | new TR1 out, Lombard Odier Asset Management | ultrasilva | |
19/2/2021 11:31 | The important thing is that the chart is still in play. | red army | |
19/2/2021 11:22 | Not clear why it fell so far yesterday..... seemed it was falling on quite low volume. | emeraldzebra | |
19/2/2021 10:39 | Not one to sell, the growth hasn’t even started yet, keen buyers on the mini dips after a few got subtly mugged! I added a few more, along with KNB,MXC,NEX & PPS all on pull backs. | ny boy | |
19/2/2021 10:30 | @Minja19 thank you. please define considerable :) | ultrasilva | |
19/2/2021 10:17 | Nice to have a chartist giving us some accurate information - Thank You Minja19 | channel pirate | |
19/2/2021 10:05 | Now due a considerable pop up | minja19 | |
19/2/2021 09:03 | Pinged off the 8 ema at open Tick up coming Fingers xxd | minja19 | |
18/2/2021 23:07 | New article on proactive investors. Tissue Regenix ready to build on strong performance through pandemic Philip Whiterow 14:10 Thu 18 Feb 2021 | ultrasilva | |
18/2/2021 20:06 | FYI Smith & Nephew revenues and profit dropped quite a lot in 2020 - because of elective surgeries postponed. TRX revenues have not... In 2020 we continued to strengthen Smith & Nephew through increased investment in R&D, new product launches and strategic acquisitions in our higher-growth segments. We achieved this while also managing unprecedented disruption from COVID-19. The resilience of the business and strength of the balance sheet also meant we are able to maintain our progressive dividend policy,” said Roland Diggelmann, chief executive of Smith & Nephew. "We start 2021 with three clear priorities: to return to top-line growth and recapture momentum; to drive further operational improvement, and to continue to respond effectively to COVID-19. We will build on the progress we are starting to make in areas where we have recently invested and introduced innovation. We will again invest more in R&D and I am excited by the pipeline of new technologies approaching launch, and by the potential of our recent acquisitions,” he added. | ultrasilva | |
18/2/2021 17:35 | Someone was suggesting a gap at 0.75p? | cyberbub | |
18/2/2021 17:19 | Which one? | dogwalker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions